Orphan Drugs Market | 2021 Global Analysis By Size, Growth Insights, Developments, Emerging Technologies, COVID-19 Impact, Share, Key Players, Trends, Regional Outlook And Global Industry Forecast To 2027 is latest study published by Fortune Business Insights. Orphan Drugs market expected to reach USD 340.84 billion value exhibiting a CAGR of 10.5% by 2027. Orphan Drugs Industry is segmented By Therapy Area (Oncology, Hematology, Neurology, Endocrinology, Cardiovascular, Respiratory, Immunotherapy, and Others), By Drug Type (Biologics, and Non-Biologics), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Sales, and Others), and Regional Forecast, 2020-2027.
Get Sample Report On Global Orphan Drugs Market: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/orphan-drugs-market-100088
Key Companies Studied In Report:
- Amgen Inc. (Thousand Oaks, U.S.)
- Bayer AG (Leverkusen, Germany)
- Hoffmann-La Roche Ltd (Basel, Switzerland)
- Alexion Pharmaceuticals Inc. (Boston, U.S.)
- Novo Nordisk A/S (Bagsværd, Denmark)
- Novartis AG (Basel, Switzerland)
- Bristol-Myers Squibb Company (New York, U.S.)
- AstraZeneca (Cambridge, U.K.)
- DAIICHI SANKYO COMPANY, LIMITED (Tokyo, Japan)
- GlaxoSmithKline plc (Brentford, U.K.)
Orphan Drugs Market Highlights:
The global orphan drugs market size is projected to reach USD 340.84 billion by the end of 2027. Increasing number of regulatory approvals will have a positive impact on the growth of the overall market in the coming years. According to a report published by Fortune Business Insights, titled “Orphan Drugs Market Size, Share & COVID-19 Impact Analysis, By Therapy Area (Oncology, Hematology, Neurology, Endocrinology, Cardiovascular, Respiratory, Immunotherapy, and Others), By Drug Type (Biologics, and Non-Biologics), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Sales, and Others), and Regional Forecast, 2020-2027,” the market was worth USD 151.00 billion in 2019 and will exhibit a CAGR of 10.5% during the forecast period, 2020-2027.
Orphan drugs are medicinal products that are intended at the treatment of severe and life—threatening conditions including cancer. They are normally associated with the treatment of very rare diseases (affecting 1 in every 2000 people). The difficulty associated with the treatment of critical diseases has yielded massive investments in research and development. The presence of numerous large scale orphan drug manufacturers across the world will emerge in favor of growth of the overall market in the coming years. The increasing number of regulatory approvals associated with orphan drugs, coupled with increasing clinical trials related to these drugs will create several growth opportunities for the market in the coming years.
Orphan drugs are used for the treatment of severe and life-threatening diseases. The high emphasis on research and development of these drugs are consequential to the difficulty associated with the treatment of the disease. Due to increasing incidence of such life-threatening diseases, including cancer, there are several companies that are operating across the globe. The high prevalence of infectious diseases in developed as well as developing countries will bode well for the growth of the market in the coming years. The presence of several large scale manufacturers will contribute to the growth of the market. The increasing demand for immunomodulators in emerging as well as developed countries will have a positive impact on the growth of the overall market in the foreseeable future.
Increasing Number of Regulatory Approvals will Emerge in Favor of Orphan Drugs Market Growth
The report encompasses several factors that have contributed to the growth of the overall market in recent years. Accounting to the massive potential held by orphan drugs, there are numerous clinical trials associated with the drugs. The increasing number of successful clinical trials has resulted in an increase in the number of regulatory approvals across the world. In May 2019, Pfizer announced that it has received approval from the US Food and Drug Administration for its latest products aimed at treatment of cardiomyopathy. The company announced that it has received approval from the FDA for VYNDAQEL and VYNDAMAX, two products that have shown signs of promise in the clinical phases. Fortune Business Insights states that increasing number of such regulatory approvals for products of large scale companies will have a positive impact on the growth of the overall market in the coming years.
Our research methodology is robust and includes data triangulation based on bottom-up and top-down approaches. We validated the approximate market number with the help of primary research. Secondary research was conducted to find out detailed information about mergers and acquisitions, collaborations, joint ventures, and agreements. At the same time, we have derived significant information about the market dynamics associated with growth drivers, trends, and obstacles.
It offers figurative estimations for upcoming years on the basis of the recent developments and historic data. For gathering information and estimating revenue for all segments, researchers have used top-down and bottom-up approaches. On the basis of data collected from primary and secondary research and trusted data sources the report will help both existing and new aspirants for Orphan Drugs market to figure out and study the market’s needs, market size, and competition.
Regional Analysis:
- North America (the USA and Canada)
- Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
- Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
- Latin America (Brazil, Mexico and Rest of Latin America)
- Middle East and Africa (South Africa, GCC and Rest of the Middle East and Africa)
The report analyses the ongoing market trends across five major regions, including North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. Among all regions, the market in North America currently dominates the market. The high spending on research and development of orphan drugs, coupled with the presence of several large-scale local manufacturers will bode well for market growth. The rising demand for the product in the United States as well as Canada will also contribute to the growth of the market in the coming years. As of 2019, the market in North America was worth USD 81.22 billion and this value is projected to increase further in the coming years. The market in Europe will derive growth from the adoption of technologically advanced manufacturing equipment by major companies in the region.
This report focuses on Orphan Drugs Global Market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Regional analysis is another highly comprehensive part of the research and analysis study of the global market presented in the report. This section sheds light on the sales growth of different regional and country-level markets. For the historical and forecast period to 2027, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global market.
For More Questions, Talk with Orphan Drugs Industry Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/orphan-drugs-market-100088
Orphan Drugs Highlights of the Report:
- Market Penetration: Comprehensive information on the product portfolios of the top players in the Supply Chain Analytics market.
- Product Development/Innovation: Detailed insights on the upcoming technologies, RandD activities, and product launches in the market
- Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market
- Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the Supply Chain Analytics market
Competitive Analysis And Industry News:
Major companies in the global Orphan Drugs Market are increasingly focusing on research and development activities to create new and innovative products to stay ahead of the competition. Staying on top of market trends and drivers is crucial for decision-makers to hold this emerging opportunity. The study provides information on market trends and development, drivers, capacities, technologies, and the changing investment structure of the Orphan Drugs Industry.
Key questions answered in the report:
- What will the market growth rate of Orphan Drugs Market in 2027?
- What are the key factors driving the global Orphan Drugs Market?
- Who are the key manufacturers in Orphan Drugs Market space?
- What are the market opportunities, market risk and market overview of the Orphan Drugs Global market?
- What are sales, revenue, and price analysis of top manufacturers of Orphan Drugs Global market?
- What are sales, revenue, and price analysis by types and applications of Orphan Drugs Market?
- What are sales, revenue, and price analysis by regions of Orphan Drugs market?
Get customized Report: https://www.fortunebusinessinsights.com/enquiry/customization/orphan-drugs-market-100088
Table of Content:
1 Market Overview
1.1 Orphan Drugs Introduction
1.2 Market Analysis by Type
1.3 Market Analysis by Applications
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2020-2027)
1.4.1.2 Canada Market States and Outlook (2020-2027)
1.4.1.3 Mexico Market States and Outlook (2020-2027)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2020-2027)
1.4.2.2 France Market States and Outlook (2020-2027)
1.4.2.3 UK Market States and Outlook (2020-2027)
1.4.2.4 Russia Market States and Outlook (2020-2027)
1.4.2.5 Italy Market States and Outlook (2020-2027)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2020-2027)
1.4.3.2 Japan Market States and Outlook (2020-2027)
1.4.3.3 Korea Market States and Outlook (2020-2027)
1.4.3.4 India Market States and Outlook (2020-2027)
1.4.3.5 Southeast Asia Market States and Outlook (2020-2027)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2020-2027)
1.4.4.2 Egypt Market States and Outlook (2020-2027)
1.4.4.3 Saudi Arabia Market States and Outlook (2020-2027)
1.4.4.4 South Africa Market States and Outlook (2020-2027)
1.4.4.5 Turkey Market States and Outlook (2020-2027)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
3 Global Orphan Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Orphan Drugs Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Orphan Drugs Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Orphan Drugs Manufacturer Market Share in 2018
3.3.2 Top 6 Orphan Drugs Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Orphan Drugs Market Analysis by Regions
4.1 Global Orphan Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Orphan Drugs Sales and Market Share by Regions (2020-2027)
4.1.2 Global Orphan Drugs Revenue and Market Share by Regions (2020-2027)
4.2 North America Orphan Drugs Sales and Growth Rate (2020-2027)
4.3 Europe Orphan Drugs Sales and Growth Rate (2020-2027)
4.4 Asia-Pacific Orphan Drugs Sales and Growth Rate (2020-2027)
4.5 South America Orphan Drugs Sales and Growth Rate (2020-2027)
4.6 Middle East and Africa Orphan Drugs Sales and Growth Rate (2020-2027)
5 North America Orphan Drugs by Country
5.1 North America Orphan Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Orphan Drugs Sales and Market Share by Country (2020-2027)
5.1.2 North America Orphan Drugs Revenue and Market Share by Country (2020-2027)
5.2 United States Orphan Drugs Sales and Growth Rate (2020-2027)
5.3 Canada Orphan Drugs Sales and Growth Rate (2020-2027)
5.4 Mexico Orphan Drugs Sales and Growth Rate (2020-2027)
8 South America Orphan Drugs by Country
8.1 South America Orphan Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Orphan Drugs Sales and Market Share by Country (2020-2027)
8.1.2 South America Orphan Drugs Revenue and Market Share by Country (2020-2027)
8.2 Brazil Orphan Drugs Sales and Growth Rate (2020-2027)
8.3 Argentina Orphan Drugs Sales and Growth Rate (2020-2027)
8.4 Colombia Orphan Drugs Sales and Growth Rate (2020-2027)
9 Middle East and Africa Orphan Drugs by Countries
9.1 Middle East and Africa Orphan Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Orphan Drugs Sales and Market Share by Country (2020-2027)
9.1.2 Middle East and Africa Orphan Drugs Revenue and Market Share by Country (2020-2027)
9.2 Saudi Arabia Orphan Drugs Sales and Growth Rate (2020-2027)
9.3 Turkey Orphan Drugs Sales and Growth Rate (2020-2027)
9.4 Egypt Orphan Drugs Sales and Growth Rate (2020-2027)
9.5 Nigeria Orphan Drugs Sales and Growth Rate (2020-2027)
10 Orphan Drugs Market In Developing Countries
11 South America Orphan Drugs Market Analysis by Countries
12 Competitive Landscape
13 Industry Outlook
13.1 Market Driver Analysis
13.1.2 Market Restraints Analysis
13.1.3 Market Trends Analysis
13.2 Merger, Acquisition and New Investment
13.3 News of Product Release
14 Global Orphan Drugs Market Forecast
15 New Project Feasibility Analysis
15.1 Industry Barriers and New Entrants SWOT Analysis
15.1.1 Porter’s Five Forces Analysis
15.1.2 New Entrants SWOT Analysis
15.2 Analysis and Suggestions on New Project Investment
Continued…
About Us:
Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Contact Us:
Fortune Business Insights Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
411045, Maharashtra, India.
US: +1 424 253 0390
UK: +44 2071 939123
APAC: +91 744 740 1245